600165 宁科生物
2026/06 - 中期
人民币(K¥)
与去年末期
比较
2025/12
人民幣(K¥)
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)

非流动资产
长期股权投资0--00710,410672,169
投资性房地产3,929-52.60%8,28967,03979,82161,284
固定资产1,495,623-2.71%1,537,3341,727,0441,797,1702,121,704
在建工程128,81258.27%81,38579,42772,79074,648
无形资产58,794-2.45%60,26867,14074,31579,295
商誉0--0000
其他非流动资产41,917280.75%11,00912,11424,31317,740
1,729,0761.81%1,698,2851,952,7642,758,8193,026,839

流动资产
货币资金189,971-58.76%460,6498,60724,39989,484
应收账款119,15820.33%99,02466,84857,05732,676
存货177,50451.35%117,279102,04795,832108,421
其他流动资产125,6129.40%114,81536,74221,40720,369
612,245-22.67%791,768214,243198,695250,950

流动负债
短期借款10,00027.98%7,814226,611343,796331,340
应付票据0--00053,279
应付帐款143,14123.44%115,962820,223635,363638,678
其他流动负债109,164-32.55%161,849850,667901,912619,533
262,305-8.16%285,6261,897,5011,881,0711,642,830
流动资产净值349,940-30.86%506,142(1,683,258)(1,682,375)(1,391,880)
资产总额减流动负债2,079,016-5.69%2,204,428269,5051,076,4441,634,959

非流动负债
长期借款0--00213,800281,500
应付债券0--0000
其他非流动负债875,3920.80%868,40829,339556,990536,600
875,3920.80%868,40829,339770,790818,100

总权益
    实收股本1,615,8840.00%1,615,884684,884684,884684,884
    储备项目(540,406)32.47%(407,937)(613,090)(585,727)(125,074)
股东权益1,075,478-10.97%1,207,94671,79399,157559,810
非控股权益128,1470.06%128,074168,373206,497257,049